ABT vs THR · P/E 25, rev $44.33B vs P/E 45, rev $498.2M
Abbott Laboratories (ABT) versus Thermon Group Holdings Inc (THR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Thermon Group Holdings Inc (THR) is a specialty industrial machinery company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported THR revenue for 2025-03-31 was $498.2M. Net income was $53.5M. Revenue was up 0.7% from 2024-03-31 to 2025-03-31. THR currently screens at market cap $2.01B and trailing P/E 45.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. THR currently screens at market cap $2.01B and trailing P/E 45.0.
Not investment advice. Open the ABT and THR stock pages for the full models.
Not investment advice.